Prof. Antonio Ceriello

Prof. Antonio Ceriello

Prof Antonio Ceriello short CV

Professor Antonio Ceriello is Research Consultant at IRCCS MultiMedica, Milan, Italy and Adjunt Professor of Internal Medicine at the “Luigi Vanvitelli University” of Naples, Italy.

  • From January 2010 until June 2020 he was Principal Investigator at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • From March 2016 to December 2022 he was Head of Diabetes Department at IRCCS MultiMedica, Milan, Italy.
  • From April 2006 to December 2009 he was Professor of Endocrinology at the University of Warwick, UK.
  • From 1990 until March 2006 he was Chair of Endocrinology and Director of the School of Specialty in Geriatrics at the University of Udine, Italy.
  • From 2004 to 2006 he also was Adjunct Professor of Internal Medicine at the Oklahoma City University, U.S.A.

Professor Ceriello has widely published in diabetes, with over 550 original papers and several book chapters. His current h-index is 121 (Google Scholar). Prof Ceriello has been consultant of the National Institutes of Health, U.S.A. for the program of the research 2003-2005, related to cardiovascular disease and type 1 diabetes, and member of the writing committee of the American Heart Association of the guidelines on “Acute Hyperglycemia and Acute Coronary Syndromes”. He has also chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, he is the Chairman of the “Diabetes and Cardiovascular Diseases (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). He also served as Review of the 2012 “European Guidelines on Cardiovascular Disease Prevention in Clinical Practice” and for the 2013 “European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “. He has also been a Member of the Board for the development of the “2019 European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “and of the 2022 ADA, ADCES, EASD, ISPAD, JDS, JDRF International Consensus, endorsed by FDA and EMA, on “Continuous Glucose Monitoring (CGM) Metrics for Clinical Trials”. From 2009 to 2012 he has been member of the Board of the IDF Europe and Consultant of the EU Commission for the Framework “Diabetes as a model of chronic care management”. He served as Referee of the European Commission for the 2017 grant program related to the HORIZON 2020 Program. From 2013 to 2015 he has been the President of the Associazione Medici Diabetologi (AMD), and from 2015 to 2017 President of the AMD Foundation.

He also served as Associate Editor of “Diabetes Care” from 2003 to 2011 and Associate Editor of “Diabetic Medicine” from 2005 to 2016. From July 1st 2016 he has been appointed as Editor in Chief of “Diabetes Research and Clinical Practice”, the official IDF journal (Current IF 8.18). Currently he is also in the Editorial Board of “Cardiovascular Diabetology”. Prof. Ceriello is the winner in the 1984 of the “Italian Annual Award for Young Researcher”, in the 1990 of the “Italian National Award for Research on the Pathophysiology of Diabetic Complications”, in the 1998 of the “National Award Italian Society of Diabetology”, in the 2004 of the “Camillo Golgi Prize” of the EASD, in the 2017 of the “Hellmut Mehnert Award”, during the 2017 IDF Meeting, in the 2022 of the “Aretaeus Lecture Award” from the Hellenic Society of Diabetology and in 2023 of the “Somogyi Award” from the Hungarian Diabetes Association.

Prof. Ceriello is Special Advisor to the Board of IDF Europe (Advocacy and Publications) for 2023-2024.

Prof. Ceriello has also been appointed by IDF as Co-Chairman for the development of the “2023 Guidelines for the management of type 2 diabetes in different settings” and as Chairman for the 2024 IDF World Congress. He is also currently appointed as IDF Representative for the following activities:

  • Global action for developing a research and action roadmap for fatty liver disease.
  • IDF-ISN policy brief on diabetic nephropathy (in cooperation with WHO).
  • Development of Obesity Clinical Practice recommendation and education project (in cooperation with WOF).